MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.
MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial. J Magn Reson Imaging. 2017 07; 46(1):290-302.